Given that CREPT exhibited strikingly higher expression in tumor tissues and its inhibition showed comparable inhibitory effects to CDK9 inhibitors on tumor growth, we hypothesize that targeting CREPT may provide an alternative and potentially more specific strategy for LUAD treatment. The gene discussed is CDK9; the disease is neoplasm.